Press Release: Climedo Health Publishes Whitepaper about the Impact of COVID-19 on the MedTech Industry

Munich -- Tuesday, April 28, 2020. Munich-based software start-up Climedo Health has published a Whitepaper assessing the "Impact of COVID-19 on the MedTech Industry". The paper analyses four major areas that are being significantly affected by the outbreak.

Almost no industry has been left untouched by the Coronavirus outbreak. This clearly includes the MedTech sector, which manufactures many of the vital devices and products needed in the fight against the disease. Combined with disruptions in global supply chains, the high demand for certain products (personal protective equipment and ventilators) has led to massive shortages in certain areas. This is what the first part of the 13-page report by Climedo Health addresses. The second part analyses other MedTech sectors which are experiencing a temporary decline in demand due to the pandemic, such as instruments used in elective procedures. Such procedures are currently often postponed for capacity reasons. The report then looks at some innovative diagnostic and treatment examples which could serve as inspiration for companies. Finally, the consequences for the EU Medical Device Regulation (EU-MDR) are considered, which was postponed due to COVID-19, among other reasons.

"In addition to the dramatic consequences for our society and economy, the COVID-19 crisis has exposed many flaws in our global healthcare system," says Veronika Schweighart, Co-Founder and COO of Climedo. "What's interesting, however, is that the virus has served as a wake-up call for many and, in some cases, has accelerated digital transformation in a way that would have taken much longer under normal circumstances. As this will certainly not be our last pandemic, we will hopefully be (even) better prepared next time. With more transparency, more efficient processes and an openness towards digital solutions, many of the problems that companies are currently experiencing could be avoided or at least solved more quickly in future."

The free Whitepaper is now available for download on the Climedo homepage.

Climedo Health GmbH
Schellingstr. 109 A
80798 Munich
Germany

Climedo's mission is to bring the best treatment to every patient by empowering healthcare professionals with intelligent software solutions.

Together with Europe's leading hospitals, we have developed a cloud-based platform for cutting-edge clinical validation of medical devices and pharmaceutical products.

By digitally connecting all stakeholders (Medical Device manufacturers, Pharma companies, CROs, hospitals and patients), Climedo allows for increased performance, better cost-efficiencies - and ultimately - accelerated medical innovation.

This release was published on openPR.